Axonics
AXNX · NASDAQ
$0.429−$0.0611 (−12.47%)TodayMarket closed ·
Prev close $0.4901
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 147.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q3 FY24 | $0.1355 | $0.00 | −100.0% |
| Q2 FY24 | $0.1313 | $0.13 | −1.0% |
| Q1 FY24 | -$0.0857 | -$0.27 | −215.1% |
| Q4 FY23 | $0.0594 | $0.13 | +118.9% |
| Q3 FY23 | -$0.0561 | $0.08 | +242.6% |
| Q2 FY23 | -$0.1159 | $0.16 | +238.1% |
| Q1 FY23 | -$0.2931 | -$0.19 | +35.2% |
| Q4 FY22 | -$0.2465 | $0.01 | +104.1% |
Earnings calls
- 5th Annual Wolfe Research Healthcare Conference 2023
- AXNX - Earnings call 3 2023
- Morgan Stanley 21st Annual Global Healthcare Conference 2023
- Earnings call Q2 2023
- AXNX - Earnings call Q2 2023
- Bank of America Securities 2023 Healthcare Conference
- Earnings call Q1 2023
- Earnings call Q4 2022
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.